Currax Pharmaceuticals

Currax Pharmaceuticals 是一家在股票代码 OREX (US) 下上市的公司。

查看带有其 8 名主要高管的组织结构图

Currax Pharmaceuticals 搜索最多的简介

• George Hampton, Chief Executive Officer
• Aaron Chesnut, Vice President, Technical Operations
• Michael Kyle, Senior Vice President and Chief Medical Officer

创建提醒
跟踪 Currax Pharmaceuticals 的高管变动

Currax Pharmaceuticals 拥有 1,837 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。

Popular M&A news in 药店

• Grace Therapeutics将在Oct 24, 2024将其名称改为Grace Therapeutics。 (公布2024十月27号).
• Orasis Pharmaceuticals 刚刚宣布为 78 筹款数百万美元。 (公布2024十月21号).
• Lundbeck has announced the acquisition of Longboard Pharmaceuticals  (公布2024十月17号).

药店 行业的其他推荐联系人

• Sanofi 企业 Julie Van Ongevalle - Executive Vice President and Head of Consumer Healthcare
• Amneal Pharmaceuticals 企业 Paul Meister - Chairman of the Board
• Braeburn Pharmaceuticals 企业 Seth Harrison - Chairman and Director

了解更多有关药店行业的信息 >

Currax Pharmaceuticals 的最新新闻稿

• Currax  —   Currax™ Pharmaceuticals LLC Announces First Acquisition: Acquires North American Rights to ONZETRA® Xsail®
• Currax  —   Currax Pharmaceuticals Delivers Strong Operational and Financial Performance Eight Months into Operations
• Currax  —   Currax™ Pharmaceuticals LLC Announces the Acquisition of Nalpropion Pharmaceuticals, Inc.
• Currax  —   Currax™ Holdings USA LLC Announces Launch and Close of Acquisition

关于 Currax Pharmaceuticals 的社交媒体

• Currax Pharmaceuticals 在 维基百科、谷歌新闻 和 雅虎财经
• Currax Pharmaceuticals 在 LinkedIn、叽叽喳喳 和 YouTube

通过电子邮件联系联系该企业高管，包括 George Hampton

致电Currax Pharmaceuticals，电话：+1 858...

查看组织结构图

Register to receive your alert

报告错误